Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd
Shenzhen Stock ExchangeTotal Valuation
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd carries a market capitalization of 16.74B, placing it among publicly traded companies globally. Its enterprise value stands at 26.00B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 16.74B |
| Enterprise Value | 26.00B |
Share Statistics
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd currently has 966.49M shares outstanding.
| Shares Outstanding | 966.49M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd trades at a trailing price-to-earnings ratio of 402.94. The price-to-sales ratio is 18.50, and the price-to-book ratio stands at -18.88.
| PE Ratio | 402.94 |
| PS Ratio | 18.50 |
| PB Ratio | -18.88 |
| P/TBV Ratio | 12.89 |
| P/FCF Ratio | 560.43 |
| P/OCF Ratio | N/A |
Enterprise Valuation
On an enterprise value basis, Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd trades at an EV/EBITDA multiple of 162.22 and an EV/FCF ratio of 236.46. The EV/Sales ratio of 19.65 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 162.22 provides insight into valuation relative to core operating earnings.
| EV / Sales | 19.65 |
| EV / EBITDA | 162.22 |
| EV / EBIT | 162.22 |
| EV / FCF | 236.46 |
Financial Position
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd maintains a current ratio of 0.58, meaning it holds 0.6x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 81.69, indicating elevated leverage, while an interest coverage ratio of 1.88 demonstrates limited ability to service its debt obligations.
| Current Ratio | 0.58 |
| Quick Ratio | 0.16 |
| Debt / Equity | 81.69 |
| Debt / EBITDA | 11.58 |
| Interest Coverage | 1.88 |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | 1.33 |
| Return on Invested Capital (ROIC) | 3.03 |
| Return on Capital Employed (ROCE) | 25.35 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 0.91 |
Taxes
Over the trailing twelve months, Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd has paid 17.24M in income taxes, reflecting an effective tax rate of 22.19.
| Income Tax | 17.24M |
| Effective Tax Rate | 22.19 |
Stock Price Statistics
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd's stock has declined approximately -28.51837% over the past 52 weeks. The 50-day moving average sits at 23.61, while the 200-day moving average is 24.67.
| Beta (5Y) | N/A |
| 52-Week Price Change | -28.51837% |
| 50-Day Moving Average | 23.61 |
| 200-Day Moving Average | 24.67 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd generated 1.32B in revenue and converted that into 60.77M in net income, yielding earnings per share of 0.06. EBITDA reached 160.28M, while operating income came in at 160.28M.
| Revenue | 1.32B |
| Gross Profit | 979.15M |
| Operating Income | 160.28M |
| Pretax Income | 77.72M |
| Net Income | 60.77M |
| EBITDA | 160.28M |
| EBIT | 160.28M |
| Earnings Per Share (EPS) | 0.06 |
Balance Sheet
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd holds 344.76M in cash and equivalents against 1.86B in total debt, resulting in a net debt position of -93.97M. Total book value stands at -1.30B, with working capital of -913.59M providing operational flexibility.
| Cash & Cash Equivalents | 344.76M |
| Total Debt | 1.86B |
| Net Debt | -93.97M |
| Equity (Book Value) | -1.30B |
| Book Value Per Share | -1.34 |
| Working Capital | -913.59M |
Cash Flow
After subtracting -43.69M in capital expenditures, free cash flow totaled -43.69M - equivalent to -0.05 per share.
| Operating Cash Flow | N/A |
| Capital Expenditures | -43.69M |
| Free Cash Flow | -43.69M |
| FCF Per Share | -0.05 |
Margins
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd operates with a gross margin of 73.99, reflecting its pricing power and cost economics. The operating margin of 12.11 and net profit margin of 4.59 provide insight into operational efficiency.
| Gross Margin | 73.99 |
| Operating Margin | 12.11 |
| Pretax Margin | 5.87 |
| Profit Margin | 4.59 |
| EBITDA Margin | 12.11 |
Dividends & Yields
The company's payout ratio of 138.56 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 0.09 |
| Dividend Yield | N/A |
| Payout Ratio | 138.56 |
| Shareholder Yield | 0.30 |
| FCF Yield | 0.18 |
Stock Splits
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd's most recent stock split took place on May 25, 2001 with a 2:3 split ratio.
| Last Split Date | 5/25/2001 |
| Split Ratio | 2:3 |
Scores
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd posts an Altman Z-Score of 5.91, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 5.91 |